Allied Academies
Cancer
Stem Cells: Targeting the Roots of Cancer
Allied academies
medical meetings
Allied Academics welcomes you to
attend the 10th International Conference on Cancer Stem Cells and Regenerative Medicine, during June
29-30, 2017 in London, UK. We cordially invite all the participants who are
interested in sharing their knowledge and research in the arena of Cancer Stem
Cells and its applications with the theme " Cancer Stem Cells: Targeting
the Roots of Cancer."
Cancer stem
cells (CSCs) are cancer cells (found within tumors or haematological cancers)
that possess characteristics associated with normal stem cells, specifically
the ability to give rise to all cell types found in a particular cancer sample.
CSCs are therefore tumorigenic (tumour-forming), perhaps in contrast to other
non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell
processes of self-renewal and differentiation into multiple cell types. Such
cells are hypothesized to persist in tumors as a distinct population and cause
relapse and metastasis by giving rise to new tumors. Therefore, development of
specific therapies targeted at CSCs holds hope for improvement of survival and
quality of life of cancer patients, especially for patients with metastatic
disease.
Global
Market Study of Cancer Stem Cells and Regenerative Medicine:
USA: According to a
report published by W.H.O cancer fatalities are expected to increase from 14
million in 2012 to 22 million in 2020, 8.2 million deaths worldwide were due to
cancer, colorectal cancer constituted 8.4%, breast cancer constituted 6.0% and
liver constituted 9.0% in 2012.
Europe: Global Cancer stem cell market is expected to
grow at a CAGR of 23% for the forecasted period of 2015-2020. Cancer Stem cell
research is also being used to study genetic disorders, birth defects and other
growth factors.
Middle
East:
Cancer Stem Cell
Therapy
was conditionally approved in Canada in 2012 .Mesenchymal Stem Cells are
purified from the marrow, cultured and packaged, with up to 10,000 doses
derived from a single donor. The doses are stored frozen until needed.
Asia
Pacific:
According to a new market research report, ‘Global Cancer Stem Cell Market – Growth,
Trends & Forecasts (2015-2020)’, published by Mordor Intelligence, the
Global market is expected to be worth US$ 30.25 billion by the end of 2020, The
Global market for Stem Cells is expected to grow at a CAGR of 13.7% during the
period of (2015-2020).
Anyone interested in the future of
emerging Oncology techniques majorly in Cancer Stem Cells 2017 to attend, Connect
with our social network pages to get regular industry updates.
About Allied academies: Allied academies own and operate several academic
journals and conferences. Since its establishment 1995, Allied Academies
promotes peer reviewed healthcare information through meetings, scholarly journals,
and training to leading
academic, business and research institutes across the healthcare and life
science industries.
Program Coordinator
Liza Smith
Allied Academies, P.O. Box 670, Candler, NC 28715, USA, Email:cancerstemcells@alliedconferences.org